You are here: Industry Insights > NHS

News List

Gov’t announces £36m AI research funding boost for NHS pharmatimes
June 21, 2021
The UK government has announced a hefty £36bn funding boost for artificial intelligence (AI) research technologies in a bid to help the ‘NHS transform [...] quality of care’.
Researchers develop COVID-19 antibody test to detect new variants pharmatimes
June 18, 2021
New antibody tests that can detect if an individual has been exposed to COVID-19 variants have been developed by scientists from the University of Aberdeen.
NICE broadens access to treatments for rheumatoid arthritis pharmatimes
June 16, 2021
The National Institute for Health and Care Excellence (NICE) has published final draft guidance broadening access to several treatment for patients with moderate to severe rheumatoid arthritis.
Royal College of Surgeons calls for creation of ‘surgical hubs’ to tackle backlog pharmatimes
June 01, 2021
The creation of special ‘surgical hubs’ could help to address the ‘colossal’ backlog of elective surgery, the Royal College of Surgeons (RCS) has announced.
60 million doses of COVID-19 vaccine administered in UK worldpharmanews
May 25, 2021
Health services across the UK have now administered a total of around 60.6 million vaccines since 8 December, including around 37.9 million people with their first dose (72%) and 22.6 million with both doses (43%), ensuring they have the strongest ...
NHS England funds first national metastatic breast cancer audit pharmatimes
May 25, 2021
NHS England (NHSE) has announced that it will fund the first ever national metastatic breast cancer audit, in a bid to provide accurate figures of how many people in England are living with secondary breast cancer.
NHS patients with rare blood disorders gain access to Ultomiris pharmatimes
May 21, 2021
NHS patients with paroxysmal nocturnal haemoglobinuria (PNH) or atypical haemolytic uraemic syndrome (aHUS) are to get access to treatment with Alexion's Ultomiris (ravulizumab) following a green light from cost regulators.
UK trial tests third doses of COVID-19 vaccines pharmatimes
May 20, 2021
A clinical trial has launched in the UK to test the safety and effectiveness of administering a third dose of seven different COVID-19 vaccines.
Keytruda wins NICE backing in MSI-H/dMMR colorectal cancer pharmatimes
May 17, 2021
MSD’s immunotherapy Keytruda has gained UK National Institute for Health and Care Excellence (NICE) backing as a first-line treatment for certain colorectal cancer patients.
UK NICE rejects NHS use of ozanimod for MS treatment pharmaceutical-technology
May 17, 2021
The UK National Institute for Health and Care Excellence (NICE) has decided not to recommend ozanimod for the treatment of relapsing multiple sclerosis (MS) patients on National Health Service (NHS) in England and Wales.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page